by Asmaa Javed | Dec 30, 2022 | Press Releases
Cobimetinib is an anti-cancer medication that was first approved for the treatment of melanomas.
by Kathy Brewer | Dec 4, 2022 | News
Sharing a year of hope with the ECD community! View the 2022 Year-End Newsletter. Over the past two years, the ECD Global Alliance adjusted to the new norms of distancing and travel bans with more online connections and smaller, regional meetings. We have launched a...
